CJC No DAC with Ipamorelin

$95.00

Description

CJC-1295 (No DAC) combined with Ipamorelin is a peptide blend studied for its role in growth hormone release and regulatory signaling pathways. This combination is commonly utilized in laboratory research focused on pulsatile GH secretion and endocrine system function.

Research Focus

  • Growth hormone pulsatility studies

  • Endocrine system signaling

  • Recovery and repair models

  • Sleep and circadian rhythm research

Specifications

  • Blend: CJC-1295 (No DAC) + Ipamorelin

  • Total Content: 5mg

  • Form: Lyophilized powder

  • Purity: ≥99%

  • Storage: Refrigeration recommended (2–8°C)

  • Reconstitution: Bacteriostatic water (laboratory use)

Handling & Storage

Store in a cool, dry environment prior to reconstitution. After reconstitution, maintain refrigeration and avoid exposure to heat and light to preserve compound stability.

Disclaimer

For laboratory research use only.
Not for human consumption.
Not intended for medical, diagnostic, or therapeutic use.

Description

CJC-1295 (No DAC) combined with Ipamorelin is a peptide blend studied for its role in growth hormone release and regulatory signaling pathways. This combination is commonly utilized in laboratory research focused on pulsatile GH secretion and endocrine system function.

Research Focus

  • Growth hormone pulsatility studies

  • Endocrine system signaling

  • Recovery and repair models

  • Sleep and circadian rhythm research

Specifications

  • Blend: CJC-1295 (No DAC) + Ipamorelin

  • Total Content: 5mg

  • Form: Lyophilized powder

  • Purity: ≥99%

  • Storage: Refrigeration recommended (2–8°C)

  • Reconstitution: Bacteriostatic water (laboratory use)

Handling & Storage

Store in a cool, dry environment prior to reconstitution. After reconstitution, maintain refrigeration and avoid exposure to heat and light to preserve compound stability.

Disclaimer

For laboratory research use only.
Not for human consumption.
Not intended for medical, diagnostic, or therapeutic use.